
Browse
	Faculties & Departments
	Issue Date
	Author
	Title
	Communities & Collections

Sign on to:
	My DSpace authorized users

Search Results

Search:

for

Results 1-22 of 22.

Sort items by In order | Results/Page Authors/record

Item hits:

Issue Date	Title	Author(s)
2010	Autologe stamceltransplantatie bij hematologische aandoeningen, 1980-2002	Beckers, M.M.; Verdonck, L.F.; Cornelissen, J.J.; Schattenberg, A.V.M.B.; Janssen, J.J.M.; Willemze, R.; Imhoff, G.W. van; Lelie, J.H. van der; Wijermans, P.; Schaafsma, R.; Baars, J.; Marwijk Kooij, M.R. van; Biesma, D.H.; Biezen, A. van; Brand, R.; Schouten, H.C.
2010	Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia.	Deenik, W.; Janssen, J.J.M.; Holt, B. van der; Verhoef, G.E.; Smit, W.M.; Kersten, M.J.; Daenen, S.M.G.J.; Verdonck, L.F.; Ferrant, A.; Schattenberg, A.V.M.B.; Sonneveld, P.; Marwijk Kooy, M. van; Wittebol, S.; Willemze, R.; Wijermans, P.W.; Beverloo, H.B.; Lowenberg, B.; Valk, P.J.; Ossenkoppele, G.J.; Cornelissen, J.J.
2009	Allogene stamceltransplantatie in Nederland	Schattenberg, A.V.M.B.; Schouten, H.C.; Verdonck, L.F.; Willemze, R.; Lelie, J. van der; Huijgens, P.C.; Imhoff, G.W. van; Biezen, A. van; Brand, R.; Hagenbeek, A.; Witte, T.J.M. de; Cornelissen, J.J.
2009	Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.	Avivi, I.; Montoto, S.; Canals, C.; Maertens, J.; Al-Ali, H.K.; Mufti, G.J.; Finke, J.; Schattenberg, A.V.M.B.; Fanin, R.; Cornelissen, J.J.; Vernant, J.P.; Russell, N.; Beguin, Y.; Thomson, K.; Verdonck, L.F.; Kobbe, G.; Tilly, H.; Socie, G.; Sureda, A.
2008	Results of hematopoietic stem cell transplantation after treatment with different high-dose total-body irradiation regimens in five Dutch centers.	Kempen-Harteveld, ML van; Brand, R.; Kal, H.B.; Verdonck, L.F.; Hofman, P.; Schattenberg, A.V.M.B.; Maazen, R.W.M. van der; Cornelissen, J.J.L.M.; Eijkenboom, W.M.H.; Lelie, JP van der; Oldenburger, F.; Barge, R.M.; Biezen, A. van; Vossen, J.M.J.J.; Noordijk, E.M.; Struikmans, H.
2008	Dose-finding study of imatinib in combination with intravenous cytarabine: feasibility in newly diagnosed patients with chronic myeloid leukemia.	Deenik, W.; Holt, B. van der; Verhoef, G.E.; Smit, W.M.; Kersten, M.J.; Kluin-Nelemans, H.C.; Verdonck, L.F.; Ferrant, A.; Schattenberg, A.V.M.B.; Janssen, J.J.H.M.; Sonneveld, P.; Kooy, M van Marwijk; Wittebol, S.; Willemze, R.; Wijermans, P.W.; Westveer, P.H.; Beverloo, H.B.; Valk, P. van de; Lowenberg, B.; Ossenkoppele, G.J.; Cornelissen, J.J.L.M.
2007	Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON).	Verdonck, L.F.; Notenboom, A.; Jong, D.D. de; MacKenzie, M.A.; Verhoef, G.E.; Kramer, M.H.; Ossenkoppele, G.J.; Doorduijn, J.K.; Sonneveld, P.; Imhoff, G.W. van
2007	High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia : A prospective randomized phase III study	Deenik, W.; Holt, B. van der; Verhoef, G.E.; Schattenberg, A.V.M.B.; Verdonck, L.F.; Daenen, S.M.G.J.; Zachee, P.; Westveer, P.H.; Smit, W.M.; Wittebol, S.; Schouten, H.C.; Lowenberg, B.; Ossenkoppele, G.J.; Cornelissen, J.J.L.M.
2007	Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma.	Gahrton, G.; Iacobelli, S.; Bandini, G.; Bjorkstrand, B.; Corradini, P.; Crawley, C.; Hegenbart, U.; Morgan, G.; Kroger, N.; Schattenberg, A.V.M.B.; Schonland, S.O.; Verdonck, L.F.; Volin, L.; Witte, T.J.M. de; Niederwieser, D.
2006	Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma.	Donk, N.W. van de; Kroger, N.; Hegenbart, U.; Corradini, P.; San Miguel, J.; Goldschmidt, H.M.G.; Perez-Simon, J.A.; Zijlmans, M.; Raymakers, R.A.P.; Montefusco, V.; Ayuk, F.A.; Oers, M.H. van; Nagler, A.; Verdonck, L.F.; Lokhorst, H.M.
2006	Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice.	Mutis, T.; Rijn, R.S. van; Simonetti, E.R.; Aarts-Riemens, T.; Emmelot, M.E.; Bloois, L. van; Martens, A.; Verdonck, L.F.; Ebeling, S.B.
2006	Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma.	Donk, N.W. van de; Kroger, N.; Hegenbart, U.; Corradini, P.; San Miguel, J.; Goldschmidt, H.M.G.; Perez-Simon, J.A.; Zijlmans, M.; Raymakers, R.A.P.; Montefusco, V.; Ayuk, F.A.; Oers, M.H. van; Nagler, A.; Verdonck, L.F.; Lokhorst, H.M.
2005	The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants.	Gahrton, G.; Iacobelli, S.; Apperley, J.; Bandini, G.; Bjorkstrand, B.; Blade, J.; Boiron, J.M.; Cavo, M.; Cornelissen, J.J.L.M.; Corradini, P.; Kroger, N.; Ljungman, P.; Michallet, M.; Russell, N.H.; Samson, D.; Schattenberg, A.V.M.B.; Sirohi, B.; Verdonck, L.F.; Volin, L.; Zander, A.; Niederwieser, D.
2005	Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma.	Imhoff, G.W. van; Holt, B. van der; MacKenzie, M.A.; Ossenkoppele, G.J.; Wijermans, P.W.; Kramer, M.H.; Veer, M.B. van 't; Schouten, H.C.; Marwijk-Kooy, M. van; Oers, M.H. van; Raemaekers, J.M.M.; Sonneveld, P.; Meulendijks, L.A.; Kluin, P.; Kluin-Nelemans, H.C.; Verdonck, L.F.
2005	Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40.	Imhoff, G.W. van; Holt, B. van der; MacKenzie, M.A.; Veer, M.B. van 't; Wijermans, P.W.; Ossenkoppele, G.J.; Schouten, H.C.; Sonneveld, P.; Steijaert, M.M.; Kluin, P.; Kluin-Nelemans, H.C.; Verdonck, L.F.
2005	Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalities.	Straaten, H.M. van der; Biezen, A. van; Brand, R.; Schattenberg, A.V.M.B.; Egeler, R.M.; Barge, R.M.; Cornelissen, J.J.L.M.; Schouten, H.C.; Ossenkoppele, G.J.; Verdonck, L.F.
2004	The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myeloma.	Lokhorst, H.M.; Wu, K.; Verdonck, L.F.; Laterveer, L.; Donk, N.W. van de; Oers, M.H. van; Cornelissen, J.J.L.M.; Schattenberg, A.V.M.B.
2004	The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients.	Ossenkoppele, G.J.; Graveland, W.J.; Sonneveld, P.; Daenen, S.M.G.J.; Biesma, D.H.; Verdonck, L.F.; Schaafsma, M.R.; Westveer, P.H.; Peters, G.J.; Noordhuis, P.; Muus, P.; Selleslag, D.; Holt, B. van der; Delforge, M.; Lowenberg, B.; Verhoef, G.E.
1997	Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation	Lokhorst, H.M.; Schattenberg, A.V.M.B.; Cornelissen, J.J.L.M.; Thomas, L.L.M.; Verdonck, L.F.
1995	Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.	Kolb, H.J.; Schattenberg, A.V.M.B.; Goldman, J.; Hertenstein, B.; Jacobsen, N.; Arcese, W.; Ljungman, P.; Ferrant, A.; Verdonck, L.F.; Niederwieser, D.; Rhee, F. van; Mittermuehler, J.; Witte, T.J.M. de; Holler, E.; Ansari, H.
1995	An update of prognostic factors for allogeneic bone marrow transplantation in multiple myeloma using matched sibling donors	Gahrton, G.; Tura, S.; Ljungman, P.; Blade, J.; Cavo, M.; Laurenzi, A.; Facon, T.; Gratwohl, A.; Michallet, M.; Nikoskelainen, A.; Pearce, R.; Reiffers, J.; Samson, D.; Schattenberg, A.V.M.B.; Verdonck, L.F.; Vernant, J.P.; Volin, L.
1995	Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with agressive non-Hodgkin's lymphoma	Verdonck, L.F.; Putten, W.L.J. van; Hagenbeek, A.; Schouten, H.C.; Sonneveld, P.; Imhoff, G.W. van; Kluin-Nelemans, H.C.; Raemaekers, J.M.M.; Oers, R.H.J. van; Haak, H.L.; Schots, R.; Dekker, A.W.; Gast, C. de; Löwenberg, B.